154 related articles for article (PubMed ID: 24322188)
1. Nonalcoholic fatty liver disease in menopausal women.
Florentino GS; Cotrim HP; Vilar CP; Florentino AV; Guimarães GM; Barreto VS
Arq Gastroenterol; 2013; 50(3):180-5. PubMed ID: 24322188
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
4. The influence of metabolic factors for nonalcoholic Fatty liver disease in women.
Chung GE; Yim JY; Kim D; Lim SH; Yang JI; Kim YS; Yang SY; Kwak MS; Kim JS; Cho SH
Biomed Res Int; 2015; 2015():131528. PubMed ID: 25973422
[TBL] [Abstract][Full Text] [Related]
5. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
8. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.
Hamaguchi M; Kojima T; Ohbora A; Takeda N; Fukui M; Kato T
World J Gastroenterol; 2012 Jan; 18(3):237-43. PubMed ID: 22294826
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
Liu P; Ma F; Lou H; Zhu Y; Chen Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):53-7. PubMed ID: 24721245
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
[TBL] [Abstract][Full Text] [Related]
11. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
Abid A; Taha O; Nseir W; Farah R; Grosovski M; Assy N
J Hepatol; 2009 Nov; 51(5):918-24. PubMed ID: 19765850
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.
Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Pennell CE; de Klerk N; Oddy WH; Shipman P; Adams LA
Hepatology; 2011 Mar; 53(3):800-9. PubMed ID: 21374659
[TBL] [Abstract][Full Text] [Related]
13. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Brzozowska MM; Ostapowicz G; Weltman MD
J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
[TBL] [Abstract][Full Text] [Related]
14. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
Shieh K; Gilchrist JM; Promrat K
Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
[TBL] [Abstract][Full Text] [Related]
16. Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD.
Kotoh K; Nakamuta M; Fukushima M; Morizono S; Enjoji M; Nawata H
Hepatogastroenterology; 2007; 54(73):224-8. PubMed ID: 17419265
[TBL] [Abstract][Full Text] [Related]
17. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.
Codes L; Asselah T; Cazals-Hatem D; Tubach F; Vidaud D; Paraná R; Bedossa P; Valla D; Marcellin P
Gut; 2007 Mar; 56(3):390-5. PubMed ID: 17005762
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used.
Caballería L; Pera G; Rodríguez L; Auladell MA; Bernad J; Canut S; Torán P
Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1007-11. PubMed ID: 22668875
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
Cho GJ; Shin JH; Yi KW; Park HT; Kim T; Hur JY; Kim SH
Menopause; 2011 Oct; 18(10):1120-4. PubMed ID: 21694651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
